The invention refers to novel propenecarboxylic acid amidoxime derivatives
furthermore N-oxides and/or geometrical isomers and/or optical isomers
and/or pharmaceutically suitable acid addition salts and/or quaternary
derivatives thereof. The novel compounds are suitable for the treatment
of a state connected with oxygen deficit and/or energy deficit, or a
disease based on PARP inhibition, especially an autoimmune or
neurodegenerative disease, and/or a viral disease, and/or a disease
caused by a toxic effect.
